These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29067176)

  • 1. Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation.
    Kirkby Shaw K; Rausch-Derra LC; Rhodes L
    Vet Med Sci; 2016 Feb; 2(1):3-9. PubMed ID: 29067176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs.
    Nagahisa A; Okumura T
    J Vet Pharmacol Ther; 2017 Jun; 40(3):285-292. PubMed ID: 27597397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis.
    Rausch-Derra L; Huebner M; Wofford J; Rhodes L
    J Vet Intern Med; 2016 May; 30(3):756-63. PubMed ID: 27075237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal-stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor.
    Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
    Osteoarthritis Cartilage; 2009 May; 17(5):686-92. PubMed ID: 19010065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity.
    Lejeune M; Leung P; Beck PL; Chadee K
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1097-105. PubMed ID: 20813914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonists.
    Chandrasekhar S; Yu XP; Harvey AK; Oskins JL; Lin C; Wang X; Blanco MJ; Fisher MJ; Kuklish SL; Schiffler MA; Vetman T; Warshawsky AM; York JS; Bendele AM; Chambers MG
    Pharmacol Res Perspect; 2017 Jun; 5(3):e00316. PubMed ID: 28603634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
    Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and toxicokinetic profiles associated with daily oral administration of grapiprant, a selective antagonist of the prostaglandin E2 EP4 receptor, to cats.
    Rausch-Derra LC; Rhodes L
    Am J Vet Res; 2016 Jul; 77(7):688-92. PubMed ID: 27347820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Grapiprant and Its Stability Testing under Changing Environmental Conditions.
    Gumułka P; Tarsa M; Dąbrowska M; Starek M
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
    Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2-stimulated prostanoid EP4 receptors induce prolonged de novo prostaglandin E2 synthesis through biphasic phosphorylation of extracellular signal-regulated kinases mediated by activation of protein kinase A in HCA-7 human colon cancer cells.
    Fujino H; Seira N; Kurata N; Araki Y; Nakamura H; Regan JW; Murayama T
    Eur J Pharmacol; 2015 Dec; 768():149-59. PubMed ID: 26518053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.
    Hoang KG; Allison S; Murray M; Petrovic N
    Microvasc Res; 2015 Sep; 101():127-34. PubMed ID: 26188701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grapiprant: A snapshot of the current knowledge.
    Sartini I; Giorgi M
    J Vet Pharmacol Ther; 2021 Sep; 44(5):679-688. PubMed ID: 34057218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
    Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
    J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
    Friis UG; Stubbe J; Uhrenholt TR; Svenningsen P; Nüsing RM; Skøtt O; Jensen BL
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F989-97. PubMed ID: 15985651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
    Nataraj C; Thomas DW; Tilley SL; Nguyen MT; Mannon R; Koller BH; Coffman TM
    J Clin Invest; 2001 Oct; 108(8):1229-35. PubMed ID: 11602631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.